Настройки

Укажите год
-

Небесная энциклопедия

Космические корабли и станции, автоматические КА и методы их проектирования, бортовые комплексы управления, системы и средства жизнеобеспечения, особенности технологии производства ракетно-космических систем

Подробнее
-

Мониторинг СМИ

Мониторинг СМИ и социальных сетей. Сканирование интернета, новостных сайтов, специализированных контентных площадок на базе мессенджеров. Гибкие настройки фильтров и первоначальных источников.

Подробнее

Форма поиска

Поддерживает ввод нескольких поисковых фраз (по одной на строку). При поиске обеспечивает поддержку морфологии русского и английского языка
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Укажите год
Укажите год

Применить Всего найдено 15. Отображено 14.
20-06-2013 дата публикации

FLOWABLE TISSUE PRODUCTS

Номер: US20130158676A1
Принадлежит:

The present disclosure provides tissue fillers. The tissue fillers can include a plurality of tissue particles formed from acellular tissue matrix fragments. The tissue fillers can be used to fill tissue sites, such as voids formed after tissue resection. 1. A tissue product , comprising:a plurality of dry tissue matrix particles comprising a longest dimension between about 1 mm and 5 mm, wherein the tissue matrix particles each comprise a plurality of tissue matrix fragments having a length between about 5 μm and 300 μm, and wherein the tissue matrix fragments are formed into the tissue matrix particles.2. The tissue product of claim 1 , wherein forming the fragments into particles includes joining the fragments without use of a binder or adhesive.3. The tissue product of claim 2 , wherein the fragments are joined by convective drying.4. The tissue product of claim 1 , wherein the tissue fragments are cross-linked to one another.5. The tissue product of claim 1 , wherein the tissue particles each have a length between about 2 mm and 3 mm.6. The tissue product of claim 4 , wherein the tissue fragments are cross-linked to one another using a dehydrothermal crosslinking process.7. The tissue product of claim 1 , wherein the particles are substantially spherical.8. The tissue product of claim 1 , wherein the particles swell when contacted with water.9. The tissue product of claims 1 , wherein the particles are flowable when dry.10. The tissue product of claim 1 , wherein the particles form a porous structure with open channels between each of the particles that can support cellular ingrowth and vascularization.11. The tissue product of claim 1 , wherein the tissue fragments are elongated strands of tissue matrix.12. The tissue product of claim 1 , wherein the tissue matrix particles are dermal tissue matrix.13. The tissue product of claim 1 , wherein the tissue matrix particles are porcine tissue matrix particles.14. The tissue product of claim 1 , wherein the tissue ...

Подробнее
17-03-2022 дата публикации

TISSUE PRODUCTS WITH ACTIVE AGENTS AND METHODS OF PRODUCTION

Номер: US20220080084A1
Принадлежит:

The present disclosure relates to methods for producing tissue matrix products with active agents to achieve localized distribution and controlled active agent release. The method can include inserting a carrier element comprising a biodegradable material and active agent into surface features of a tissue matrix product. Also provided are tissue matrix products made using the disclosed methods. 1. A tissue product prepared by a process , comprising:selecting an acellular tissue matrix;positioning at least one microneedle array at a desired depth within the acellular tissue matrix; andinjecting an active agent into the acellular tissue matrix using the at least one microneedle array at a first position on the tissue matrix while controlling the injection rate and retraction rate of the microneedle array to produce a desired distribution of the active agent through a thickness of the acellular tissue matrix.2. The tissue product of claim 1 , wherein the process further comprises positioning the at least one microneedle array at a second position that is spatially distinct from the first position on the acellular tissue matrix and injecting additional active agent at the second position.3. The tissue product of claim 2 , further comprising repeatedly positioning the at least one microneedle array at least one additional position that is spatially distinct from previous injection positions on the acellular tissue matrix and injecting additional active agent.4. The tissue product of claim 1 , wherein the active agent includes antimicrobial agents claim 1 , comprising at least one of an antibacterial claim 1 , an antifungal claim 1 , an antiviral claim 1 , or an antiprotozoal agent.5. The tissue product of claim 4 , wherein the antimicrobial agent comprises chlorhexidine digluconate.6. The tissue product of claim 1 , wherein the process further comprises sterilizing the acellular tissue matrix.7. A tissue matrix product comprising:a tissue matrix;tissue matrix surface ...

Подробнее
30-03-2017 дата публикации

FLOWABLE TISSUE PRODUCTS

Номер: US20170086962A1
Принадлежит: LIFECELL CORPORATION

The present disclosure provides tissue fillers. The tissue fillers can include a plurality of tissue particles formed from acellular tissue matrix fragments. The tissue fillers can be used to fill tissue sites, such as voids formed after tissue resection. 1. A method of treatment , comprising:selecting a tissue site for treatment;selecting a plurality of dry flowable tissue matrix particles comprising a longest dimension between about 1 mm and 5 mm, wherein the tissue matrix particles each comprise a plurality of tissue matrix fragments having a length between 5 μm and 300 μm, and wherein the tissue matrix fragments are formed into the tissue matrix particles; andplacing the plurality of dry flowable tissue matrix particles on or in the tissue site.2. The method of claim 1 , wherein forming the fragments into particles includes joining the fragments without use of a binder or adhesive.3. The method of claim 2 , wherein the fragments are joined by convective drying.4. The method of claim 1 , wherein the tissue fragments are cross-linked to one another.5. The method of claim 1 , wherein the tissue particles each have a length between about 2 mm and 3 mm.6. The method of claim 4 , wherein the tissue fragments are cross-linked to one another using a dehydrothermal crosslinking process.7. The method of claim 1 , wherein the particles are substantially spherical.8. The method of claim 1 , wherein the particles swell when contacted with water.9. The method of claim 1 , wherein the particles form a porous structure with open channels between each of the particles that can support cellular ingrowth and vascularization.10. The method of claim 1 , wherein the tissue fragments are elongated strands of tissue matrix.11. The method of claim 1 , wherein the tissue matrix particles are dermal tissue matrix.12. The method of claim 1 , wherein the tissue matrix particles are porcine tissue matrix particles.13. The method of claim 1 , wherein the tissue matrix particles are acellular ...

Подробнее
07-06-2018 дата публикации

FLOWABLE TISSUE PRODUCTS

Номер: US20180153675A1
Принадлежит: LIFECELL CORPORATION

The present disclosure provides tissue fillers. The tissue fillers can include a plurality of tissue particles formed from acellular tissue matrix fragments. The tissue fillers can be used to fill tissue sites, such as voids formed after tissue resection. 1. A method for producing a tissue composition , comprising:selecting a tissue matrix;treating the tissue matrix to produce fragments having a length between about 5 μm and 300 μm; andforming the fragments into a plurality of particles, each particle having a longest dimension between about 1 mm and about 5 mm.2. The method of claim 1 , further comprising drying the particles.3. The method of claim 2 , wherein drying the particles includes subjecting the particles to a convective drying process.4. The method of claim 1 , further including treating the particles with a dehydrothermal treatment process.5. The method of claim 1 , wherein forming the fragments into a plurality of particles includes compressing groups of the fragments to produce each particle.6. The method of claim 1 , wherein forming the fragments into a plurality of particles includes placing small groups of the fragments in a cold environment to freeze the groups.7. The method of claim 6 , wherein placing small groups of the fragments in a cold environment to freeze the groups includes extruding the small groups into a cryogenic liquid.8. The method of claim 1 , wherein the plurality of particles includes substantially spherical particles.9. The method of claim 1 , wherein treating the tissue matrix to produce fragments includes milling the tissue matrix.10. The method of claim 1 , wherein the fragments are strands of tissue matrix.11. The method of claim 1 , wherein the tissue matrix is dermal tissue matrix.12. The method of claim 1 , wherein the tissue matrix is porcine tissue matrix.13. The method of claim 1 , wherein the particles are flowable.14. The method of claim 1 , wherein the tissue matrix is an acellular tissue matrix.15. A tissue product ...

Подробнее
25-07-2019 дата публикации

Tissue products with active agents and methods of production

Номер: US20190224376A1
Принадлежит: LifeCell Corp

The present disclosure relates to methods for producing tissue matrix products with active agents to achieve localized distribution and controlled active agent release. The method can include inserting a carrier element comprising a biodegradable material and active agent into surface features of a tissue matrix product. Also provided are tissue matrix products made using the disclosed methods.

Подробнее
15-10-2020 дата публикации

FLOWABLE TISSUE PRODUCTS

Номер: US20200323617A1
Принадлежит:

The present disclosure provides tissue fillers. The tissue fillers can include a plurality of tissue particles formed from acellular tissue matrix fragments. The tissue fillers can be used to fill tissue sites, such as voids formed after tissue resection. 1. A tissue product , comprising:a plurality of dry tissue matrix particles that form a flowable mass configured to fill and conform to a tissue site, wherein the particles have a radius between about 1 mm and 5 mm, wherein the tissue matrix particles each comprise a plurality of tissue matrix fragments having a length between about 5 μm and 300 μm, and wherein the tissue matrix fragments are joined to one another to form the tissue matrix particles.2. The tissue product of claim 1 , wherein the tissue matrix particles include dermal tissue matrix particles.3. The tissue product of claim 1 , wherein the tissue matrix particles include porcine tissue matrix particles.4. The tissue product of claim 1 , wherein the particles swell when contacted with water.5. The tissue product of claim 1 , wherein the particles are substantially spherical.6. The tissue product of claim 1 , wherein the particles are configured to fill a void or pocket in a tissue site.7. The tissue product of claim 1 , wherein the particles are dried.8. The tissue product of claim 7 , wherein the particles are freeze-dried.9. The tissue product of claim 7 , wherein the particles are dried by a dehydrothermal cross-linking process.10. The tissue product of claim 7 , wherein the particles are concurrently freeze-dried and treated with a dehydrothermal cross-linking process.11. The tissue product of claim 1 , wherein the fragments are formed into particles by joining the fragments without use of a binder or adhesive.12. The tissue product of claim 11 , wherein the fragments are joined by convective drying.13. The tissue product of claim 1 , wherein the particles each have a length between about 2 mm and 3 mm.14. The tissue product of claim 1 , wherein ...

Подробнее
02-03-2021 дата публикации

Acellular tissue matrix particles and flowable products comprising them

Номер: CA2859657C
Принадлежит: LifeCell Corp

The present disclosure provides tissue fillers. The tissue fillers can include a plurality of tissue particles formed from acellular tissue matrix fragments. The tissue fillers can be used to fill tissue sites, such as voids formed after tissue resection.

Подробнее
24-01-2017 дата публикации

Flowable tissue products

Номер: US9549805B2
Принадлежит: LifeCell Corp

The present disclosure provides tissue fillers. The tissue fillers can include a plurality of tissue particles formed from acellular tissue matrix fragments. The tissue fillers can be used to fill tissue sites, such as voids formed after tissue resection. The disclosure also includes methods of treating tissue using the tissue fillers. The tissue particles can each be formed of tissue fragments having certain sizes.

Подробнее
27-06-2013 дата публикации

Acellular tissue matrix particles and flowable products comprising them

Номер: CA2859657A1
Принадлежит: LifeCell Corp

The present disclosure provides tissue fillers. The tissue fillers can include a plurality of tissue particles formed from acellular tissue matrix fragments. The tissue fillers can be used to fill tissue sites, such as voids formed after tissue resection.

Подробнее
27-06-2013 дата публикации

Flowable tissue products

Номер: WO2013096252A1
Принадлежит: LIFECELL CORPORATION

The present disclosure provides tissue fillers. The tissue fillers can include a plurality of tissue particles formed from acellular tissue matrix fragments. The tissue fillers can be used to fill tissue sites, such as voids formed after tissue resection.

Подробнее
01-08-2019 дата публикации

Tissue products with active agents and methods of production

Номер: WO2019147553A1
Принадлежит: LIFECELL CORPORATION

The present disclosure relates to methods for producing tissue matrix products with active agents to achieve localized distribution and controlled active agent release. The method can include inserting a carrier element comprising a biodegradable material and active agent into surface features of a tissue matrix product. Also provided are tissue matrix products made using the disclosed methods.

Подробнее
06-08-2020 дата публикации

Tissue products with active agents and methods of production

Номер: AU2019212911A1
Принадлежит: LifeCell Corp

The present disclosure relates to methods for producing tissue matrix products with active agents to achieve localized distribution and controlled active agent release. The method can include inserting a carrier element comprising a biodegradable material and active agent into surface features of a tissue matrix product. Also provided are tissue matrix products made using the disclosed methods.

Подробнее
02-12-2020 дата публикации

Tissue products with active agents and methods of production

Номер: EP3743123A1
Принадлежит: LifeCell Corp

The present disclosure relates to methods for producing tissue matrix products with active agents to achieve localized distribution and controlled active agent release. The method can include inserting a carrier element comprising a biodegradable material and active agent into surface features of a tissue matrix product. Also provided are tissue matrix products made using the disclosed methods.

Подробнее
13-03-2018 дата публикации

Flowable tissue products

Номер: US09913705B2
Принадлежит: LifeCell Corp

The present disclosure provides tissue fillers. The tissue fillers can include a plurality of tissue particles formed from acellular tissue matrix fragments. The tissue fillers can be used to fill tissue sites, such as voids formed after tissue resection.

Подробнее